Following the Quintiles IMS Megamerger, which CRO will Enter the Healthcare Analytics Space Next?

Earlier this year a megamerger between Quintiles, the world’s largest CRO, and healthcare data and consultancy firm IMS was announced, with the combined company branded as Quintiles IMS. With a

Texcell acquisition of Vivo Science underscores the shifting Biopharma Contract Services landscape

Texcell, a French provider of biosafety contract services, recently acquired German company Vivo Science GmbH, a GLP/GMP compliant contract research test facility specialising in toxicology, immunology & virology in vivo

Evolution Infographic: The Rise & Diversification of Biologics

For our latest Data Visualisation project, the Evolution Global Team analysed historical new drug approval statistics and the current clinical trials pipeline to identify trends that highlight the rise and

Evolution Infographic – An Analysis of Biopharmaceutical Production in EMEA

Evolution Global Talent Attraction’s latest market research report looks at the capacity and content of biopharmaceutical production in Europe, the Middle East and Africa. Rather than publish a lengthy report,

Charles River Labs to Acquire Rapid Bacterial Detection System Provider Celsis International

Preclinical CRO Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has entered into a definitive agreement to acquire Celsis International Ltd. for $212 million in cash, subject

Evolution Global Talent Attraction featured on GEN JobWatch

Evolution founder and Managing Director Dr. Jason Beckwith was recently featured on monthly Genetic Engineering & Biotechnology News column JobWatch. Dr. Beckwith offered GEN an insight into the hiring practices

Scottish CRO BioOutsource Acquired by Sartorius Stedim Biotech

Scottish Contract Research Organisation BioOutsource have been acquired by global biopharmaceutical supplier Sartorius Stedim Biotech (SSB) for an undisclosed amount. The takeover strengthens SSB’s service portfolio throughout the drug development

BioReliance® Introduces Advanced In Vitro ADME and Toxicology Services Designed to Improve Drug Safety and Efficacy BioReliance® (www.bioreliance.com), Sigma-Aldrich Corporation’s (NASDAQ: SIAL) biologics and early-development services business under SAFC® Commercial